555 related articles for article (PubMed ID: 20702809)
1. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo.
Bursill CA; Castro ML; Beattie DT; Nakhla S; van der Vorst E; Heather AK; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1773-8. PubMed ID: 20702809
[TBL] [Abstract][Full Text] [Related]
2. High-density lipoproteins suppress chemokine expression and proliferation in human vascular smooth muscle cells.
van der Vorst EP; Vanags LZ; Dunn LL; Prosser HC; Rye KA; Bursill CA
FASEB J; 2013 Apr; 27(4):1413-25. PubMed ID: 23271056
[TBL] [Abstract][Full Text] [Related]
3. Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-II.
Rius C; Piqueras L; González-Navarro H; Albertos F; Company C; López-Ginés C; Ludwig A; Blanes JI; Morcillo EJ; Sanz MJ
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):96-104. PubMed ID: 23117657
[TBL] [Abstract][Full Text] [Related]
4. The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins.
Di Bartolo BA; Nicholls SJ; Bao S; Rye KA; Heather AK; Barter PJ; Bursill C
Atherosclerosis; 2011 Aug; 217(2):395-400. PubMed ID: 21571275
[TBL] [Abstract][Full Text] [Related]
5. Chemokine binding protein 'M3' limits atherosclerosis in apolipoprotein E-/- mice.
Ravindran D; Ridiandries A; Vanags LZ; Henriquez R; Cartland S; Tan JT; Bursill CA
PLoS One; 2017; 12(3):e0173224. PubMed ID: 28282403
[TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ
Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755
[TBL] [Abstract][Full Text] [Related]
7. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.
Raghu H; Lepus CM; Wang Q; Wong HH; Lingampalli N; Oliviero F; Punzi L; Giori NJ; Goodman SB; Chu CR; Sokolove JB; Robinson WH
Ann Rheum Dis; 2017 May; 76(5):914-922. PubMed ID: 27965260
[TBL] [Abstract][Full Text] [Related]
8. Gas6 Promotes Inflammatory (CCR2
Laurance S; Bertin FR; Ebrahimian T; Kassim Y; Rys RN; Lehoux S; Lemarié CA; Blostein MD
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1315-1322. PubMed ID: 28450294
[TBL] [Abstract][Full Text] [Related]
9. Chemokines in vascular dysfunction and remodeling.
Schober A
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1950-9. PubMed ID: 18818421
[TBL] [Abstract][Full Text] [Related]
10. Corosolic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice by regulating the nuclear factor-κB signaling pathway and inhibiting monocyte chemoattractant protein-1 expression.
Chen H; Yang J; Zhang Q; Chen LH; Wang Q
Circ J; 2012; 76(4):995-1003. PubMed ID: 22293444
[TBL] [Abstract][Full Text] [Related]
11. Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularization.
Cochain C; Rodero MP; Vilar J; Récalde A; Richart AL; Loinard C; Zouggari Y; Guérin C; Duriez M; Combadière B; Poupel L; Lévy BI; Mallat Z; Combadière C; Silvestre JS
Cardiovasc Res; 2010 Oct; 88(1):186-95. PubMed ID: 20501509
[TBL] [Abstract][Full Text] [Related]
12. Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets.
Schober A; Zernecke A; Liehn EA; von Hundelshausen P; Knarren S; Kuziel WA; Weber C
Circ Res; 2004 Nov; 95(11):1125-33. PubMed ID: 15528472
[TBL] [Abstract][Full Text] [Related]
13. Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
Amsellem V; Abid S; Poupel L; Parpaleix A; Rodero M; Gary-Bobo G; Latiri M; Dubois-Rande JL; Lipskaia L; Combadiere C; Adnot S
Am J Respir Cell Mol Biol; 2017 May; 56(5):597-608. PubMed ID: 28125278
[TBL] [Abstract][Full Text] [Related]
14. Combinatorial model of chemokine involvement in glomerular monocyte recruitment: role of CXC chemokine receptor 2 in infiltration during nephrotoxic nephritis.
Zernecke A; Weber KS; Erwig LP; Kluth DC; Schröppel B; Rees AJ; Weber C
J Immunol; 2001 May; 166(9):5755-62. PubMed ID: 11313419
[TBL] [Abstract][Full Text] [Related]
15. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
[TBL] [Abstract][Full Text] [Related]
16. Role of 3beta-hydroxysteroid-delta 24 reductase in mediating antiinflammatory effects of high-density lipoproteins in endothelial cells.
McGrath KC; Li XH; Puranik R; Liong EC; Tan JT; Dy VM; DiBartolo BA; Barter PJ; Rye KA; Heather AK
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):877-82. PubMed ID: 19325144
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages.
Veillard NR; Braunersreuther V; Arnaud C; Burger F; Pelli G; Steffens S; Mach F
Atherosclerosis; 2006 Sep; 188(1):51-8. PubMed ID: 16321392
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma.
Penton-Rol G; Polentarutti N; Luini W; Borsatti A; Mancinelli R; Sica A; Sozzani S; Mantovani A
J Immunol; 1998 Apr; 160(8):3869-73. PubMed ID: 9558092
[TBL] [Abstract][Full Text] [Related]
19. CC-Chemokine Ligand 2 (CCL2) Suppresses High Density Lipoprotein (HDL) Internalization and Cholesterol Efflux via CC-Chemokine Receptor 2 (CCR2) Induction and p42/44 Mitogen-activated Protein Kinase (MAPK) Activation in Human Endothelial Cells.
Sun RL; Huang CX; Bao JL; Jiang JY; Zhang B; Zhou SX; Cai WB; Wang H; Wang JF; Zhang YL
J Biol Chem; 2016 Sep; 291(37):19532-44. PubMed ID: 27458015
[TBL] [Abstract][Full Text] [Related]
20. Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma.
Han KH; Chang MK; Boullier A; Green SR; Li A; Glass CK; Quehenberger O
J Clin Invest; 2000 Sep; 106(6):793-802. PubMed ID: 10995790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
